Ipsen to acquire American biopharma company Epizyme for $247m
French pharma company Ipsen has agreed to acquire Epizyme, a Massachusetts-based commercial-stage biopharma company for an initial consideration of $247 million. Epizyme, which is listed ... Read More
Amazon officially opens new tech office in Boston, Massachusetts
Amazon has officially opened its new tech office in Boston, Massachusetts where over 2,000 employees will work on inventing and innovating on behalf of the ... Read More
Lantheus gets FDA approval for drug manufacturing facility in Billerica
Lantheus Holdings has secured approval from the US Food and Drug Administration (FDA) for the supplemental drug application (sNDA) for its isolator-based drug manufacturing facility ... Read More
Lilly to open $700m Lilly Institute for Genetic Medicine in Boston
Eli Lilly and Company (Lilly) has revealed plans to open a new research facility for genetic medicine dubbed as Lilly Institute for Genetic Medicine in ... Read More
Keltron acquires assets of pressure gauge manufacturer MIJA Industries
Keltron Corporation, a Massachusetts-based provider of life safety event management systems, has acquired the assets of pressure gauge manufacturer MIJA Industries for an undisclosed price. ... Read More
Oxford Biomedica, Homology Medicines to create AAV manufacturing JV in US
Oxford Biomedica, a UK-based gene and cell therapy company, has agreed to form a joint venture (JV) to undertake an adeno-associated virus (AAV) manufacturing and ... Read More
One80 Intermediaries acquires workers’ compensation broker PMC Insurance
One80 Intermediaries, a Boston-based specialty insurance broker, has acquired PMC Insurance Group, a wholesale broker for workers’ compensation and program manager. The financial terms of ... Read More
TriMech acquires Mastercam businesses of MACDAC and Compumachine
TriMech, a Virginia-based technology partner to engineers and manufacturers, has acquired the Mastercam CAM software businesses of MACDAC Engineering and Compumachine. The financial terms of ... Read More
Novo Nordisk signs $3.3bn deal to acquire Dicerna Pharmaceuticals
Novo Nordisk has signed a deal worth around $3.3 billion to acquire Dicerna Pharmaceuticals, a US-based biotech company focused on developing ribonucleic acid interference (RNAi) ... Read More
LightForce Orthodontics bags $50m in Series C for 3D printed braces system
LightForce Orthodontics, a maker of 3D printed braces system, has raised $50 million in a Series C round led by venture capital firm Kleiner Perkins. ... Read More